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Merkel cell replacements
Although Merkel cells are postmitotic, these cells turn over 
throughout an organism’s lifespan, implicating mitotically 
active progenitors as the source of renewal. Merkel cells 
originate from epidermal progenitors that require expres-
sion of the transcription factor Atoh1 for their specification. 
Wright and colleagues identified unipotent Atoh1+ pro-
genitors that maintain the Merkel cell population in mice. 
These Atoh1+ cells, which are located in the infundibulum 
of guard hairs and whisker follicles, proliferate and cannot 
be replaced by other resident stem/progenitor cells as pro-
genitors for adult Merkel cells. These findings are particularly 
interesting for understanding the elusive genesis of Merkel 
cell carcinoma, a type of skin cancer for which no effec-
tive treatments are available. (J Cell Biol 208:367–79, 2015) 
Selected by S. Yuspa
The science of prediction
The so-called “atopic march” describes the common 
sequence of clinical events during atopic disease, which dis-
plays increasing prevalence. Parental atopy is an indepen-
dent risk factor for atopic disease, and mutations in filaggrin, 
which render the epidermal barrier defective, also increase 
the risk of developing asthma in the presence of atopic der-
matitis (AD). Kelleher and colleagues recently reported that 
observable changes in skin barrier predate clinical AD. The 
presence of highest quartile transepidermal water loss in 
infants at 2 days and 2 months was strongly associated with 
increased prevalence of AD at 12 months, and this effect was 
independent of parental atopy or filaggrin mutational status. 
Because the results of two previous studies suggested that use 
of liberal emollients during the neonatal period may prevent 
development of AD, these findings may form the basis for 
future studies of interventions aimed at preventing AD and 
atopic disease in general. (J Allergy Clin Immunol, published 
online 22 January 2015, doi:10:1016/j.jaci.2014.12.013) 
Selected by H. Williams
Replenished tolerance
In the thymus, medullary thymic epithelial cells (mTECs) 
establish central T-cell tolerance via expression of tissue-
specific self-antigens. Progenitors for these cells have been 
detected; however, the mechanism for maintenance of 
the functional thymic medulla during the postnatal period 
remains elusive. Sekai and colleagues reported that a popula-
tion of embryonic TECs that express claudin-3 and -4 are suf-
ficient for maintaining functional mTEC regeneration as well 
as lifelong central T-cell tolerance. In addition, a minor SSEA-
1+ subpopulation of these cells contained self-renewable 
TECs, showed efficient reconstitution capacity, and had the 
ability to generate mature mTECs, although the clonogenic 
activity of these cells declined rapidly after birth concomitant 
with thymopoiesis. Improved understanding of TEC regenera-
tion may aid development of strategies to restore immune 
function after cytoablative therapies and to control autoim-
munity related to disease and aging. (Immunity 41:753–61, 
2014)  Selected by M. Amagai
Diagnosing the undiagnosable
Clinical exome sequencing (CES) has recently gained wider 
appeal as advances in next-generation sequencing technolo-
gies have increased the accuracy and decreased the cost of 
generating sequence data. In a recent issue of JAMA, two 
complementary reports described successful implementation 
of CES to diagnose previously difficult-to-diagnose cases. 
Yang and colleagues expanded their previous pilot study 
and confirmed a 25% molecular diagnosis rate in a cohort 
of 2,000 consecutive patients referred for diagnosis of sus-
pected genetic conditions. Furthermore, Lee and colleagues 
compared the effectiveness of proband-CES with that of trio-
CES, which provides data for the affected proband and both 
parents. In agreement with the Yang study, this study reported 
a 26% diagnosis rate and determined that the trio-CES was 
more sensitive than the proband-CES for genetically hetero-
geneous conditions owing to the increased ability to iden-
tify de novo variants and compound heterozygous variants. 
Together, these studies support the increased application of 
exome sequencing to diagnose genetic disorders and confirm 
the advantages of these methods over traditional molecular 
diagnostic approaches for difficult cases. (JAMA 312:1870–9, 
2014; JAMA 312:1880–7, 2014) Selected by J. Uitto
To correct the problem
The genetic blistering disease epidermolysis bullosa (EB) 
is caused by mutations of several genes, including type VII 
collagen (COL7A1) and type XVII collagen (COL17A1). 
Although treatment efforts have primarily focused on symp-
tom management, replenishment of collagen in the skin has 
shown some success. Wenzel and colleagues reported that 
intradermal injection of fibroblasts derived from geneti-
cally repaired induced pluripotent stem cells (iPSCs) gener-
ated from mice with defective COL7A1 resulted in restora-
tion of type VII collagen as well as increased skin integrity 
and resistance to blister-inducing mechanical stress in mice. 
In light of the clinical limitations inherent with geneti-
cally repaired genes, Umegaki-Arao and colleagues gener-
ated patient-specific iPSCs from keratinocytes isolated from 
patches of revertant mosaicism in affected JEB-nH patients. 
These cells differentiated into functional keratinocytes that 
expressed wild-type type XVII collagen, attributable to natu-
rally occurring spontaneous reversion of the COL17A1 gene 
in the patient. The success of this “natural gene therapy” 
approach coupled with the success of Wenzel’s group in 
correcting the symptoms of EB in vivo in mice offers excit-
ing possibilities for the future of EB treatment. (Sci Transl 
Med 6:264ra164, 2014; Sci Transl Med 6:264ra165, 2014) 
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